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Abstract
Bacterial infections trigger the expression of type I and II interferon genes but little is known about their effect on type III
interferon (IFN-l) genes, whose products play important roles in epithelial innate immunity against viruses. Here, we
studied the expression of IFN-l genes in cultured human epithelial cells infected with different pathogenic bacteria and in
the mouse placenta infected with Listeria monocytogenes. We first showed that in intestinal LoVo cells, induction of IFN-l
genes by L. monocytogenes required bacterial entry and increased further during the bacterial intracellular phase of
infection. Other Gram-positive bacteria, Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis, also
induced IFN-l genes when internalized by LoVo cells. In contrast, Gram-negative bacteria Salmonella enterica serovar
Typhimurium, Shigella flexneri and Chlamydia trachomatis did not substantially induce IFN-l. We also found that IFN-l genes
were up-regulated in A549 lung epithelial cells infected with Mycobacterium tuberculosis and in HepG2 hepatocytes and
BeWo trophoblastic cells infected with L. monocytogenes. In a humanized mouse line permissive to fetoplacental listeriosis,
IFN-l2/l3 mRNA levels were enhanced in placentas infected with L. monocytogenes. In addition, the feto-placental tissue
was responsive to IFN-l2. Together, these results suggest that IFN-l may be an important modulator of the immune
response to Gram-positive intracellular bacteria in epithelial tissues.
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Introduction
Type III interferons (IFN-III or IFN-ls) are recently described
cytokines involved in antiviral responses (for reviews [1–3]). Early
studies had suggested that they were functionally redundant with
type I interferons (IFN-I, e.g. IFN-a, IFN-b), but several reports
indicate that IFN-ls also have specific functions, particularly in
epithelial tissues [4–6]. The human genome harbours three
functional IFN-III genes: IL-29 (IFN-l1), IL-28A (IFN-l2) and
IL-28B (IFN-l3). These genes share common regulatory elements
with IFN-I genes in their promoter region, with predicted binding
sites for transcriptional factors NF-kB (nuclear factor kB), IFN
regulatory factors (IRFs, especially IRF3 and IRF7) and AP1 (a
dimeric transcription factor containing members of the JUN, FOS,
ATF and MAF protein families). Hence various cell types can co-
produce IFN-I and IFN-III in response to viral infection [3,7–9].
However, the mechanisms of regulation of IFN-I and IFN-III
encoding genes are not strictly identical. In particular, recent
reports support the fact that IFN-III, in contrast to IFN-I genes,
can be activated by the NF-kB pathway independently of IRFs
[7,10].
Another difference between the IFN-I and IFN-III pathways is
the use of distinct receptors. IFN-ls specifically interact with
a heterodimeric receptor composed of two chains, a specific
ligand-binding chain IFN-lR1 (or IL-28Ra) and the IL-10R2 (or
IL-10Rb) chain. In contrast, IFN-I are ligands of the IFNAR
receptor. Both receptors induce the JAK/STAT signaling
pathway, leading to transcriptional activation of similar sets of
IFN-responsive genes [11], albeit with different kinetics [12]. Even
though IFN-I and IFN-III display similar biological properties,
such as antiviral and antitumor activities [1–3,13,14], their
physiological roles are distinct because of the distribution of their
receptors in tissues. In fact, unlike IFNAR, the IFN-l receptor is
not detectably expressed in hematopoietic cells, fibroblasts or
endothelial cells, while it is primarily expressed in epithelial cells
and specific subsets of immune cells, therefore acting predomi-
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also reported in human liver, where it seems to play an important
role in chronic hepatitis C [17]. This particular cell tropism
explains why IFN-III is increasingly recognized as a key mediator
of immunity in specific niches.
IFN genes are expressed following recognition of microbial-
associated molecular patterns (MAMPs) by pattern recognition
receptors (PRRs), acting as sensors for microbial products at the
cell surface or in endosomal or cytosolic compartments [18]. IFN-
III genes are activated in monocyte-derived dendritic cells (DCs)
following stimulation with bacterial components, such as lipopoly-
saccharide (LPS) and other TLR4 and TLR9 ligands [2,19,20].
However, whereas the role of IFN-I in bacterial infections has
been extensively investigated [18,21,22], the role of IFN-III has
not been explored, except in two recent studies. Pietila ¨ et al. have
described that the transcription of IFN-l1 and IFN-l2/l3 mRNAs
increases in response to infection of human DCs with the Gram-
negative pathogen S. enterica sv Typhimurium [20]. We have shown
that the Gram-positive bacterium L. monocytogenes stimulates IFN-
l2 transcription during infection of epithelial cells and that this
pathogen is able to tightly control the expression of the
downstream responsive genes at chromatin level by hijacking
a chromatin-silencing complex [23,24]. This modulation by
a bacterium of IFN-III responses supports the hypothesis that
IFN-III contributes to immunity of epithelia against invading
bacteria.
So far, no bacterial species other than L. monocytogenes has been
examined for the induction of IFN-l genes in epithelial cells.
Because a wide range of bacterial pathogens colonize epithelia, it
was of interest to compare the ability of several bacterial pathogens
to induce these genes in this cell type. Here, we further detail
L. monocytogenes-mediated stimulation of IFN-l1 and IFN-l2 in
Lovo intestinal cells, and we show that there are striking
differences between bacterial species in the induction of IFN-l
genes in epithelial cells. In addition, we provide evidence that the
placenta is a tissue in which IFN-III genes are induced upon
bacterial infection and where IFN-III responses can be elicited.
Materials and Methods
Bacteria and Human Cells
Bacteria used in this study are listed in Table 1. All bacterial
strains (except Salmonella, Chlamydia and Mycobacterium) were grown
in brain-heart infusion (BHI) at 37uC, and for strains expressing
inlA, in the presence of chloramphenicol, 7 mg/ml. Salmonella was
grown in Luria-Bertani (LB) media (Difco) at 37uC. GFP-
expressing M. tuberculosis was grown from a frozen stock to mid-
log phase in 7H9 broth supplemented with albumin-dextrose-
catalase (ADC, Difco). C. trachomatis serovar L2 were grown on
HeLa cells, collected, as described [25], and stored at -80uC until
use. Human cell lines used are as follows: colon carcinoma
epithelial LoVo cells (ATCC CCL-229), in which L. monocytogenes is
efficiently internalized by the InlA and InlB pathways [26],
placental BeWo cells (ATCC CCL-98), HepG2 hepatocytes
(ATCC HB-8065), lung alveolar basal epithelial A549 cells
(ATCC CCL-185), carcinoma epithelial Caco-2 cells (ATCC
HTB-37), HEK293 embryonic kidney cells (CRL-1573) and
monocyte THP-1 (ATCC TIB-202). All cell lines were grown
under standard cell-culture conditions following ATCC recom-
mendations.
Bacterial Infections in Human Cells
Cells grown to 70–90% confluency were infected with different
bacteria at indicated multiplicity of infection (MOI) and following
standard protocols. Invasion efficiency was quantified by either
measuring bacterial loads after gentamicin treatment or by flow
cytometry. (i) Gentamicin assays. Briefly, bacteria grown to the early
stationary phase and washed twice in PBS were diluted in culture
medium to achieve a multiplicity of infection (MOI) of 10, 20, 25
or 100. Inocula were used to infect cells for the indicated time,
with extracellular bacteria killed by adding gentamicin 25 or
50 mg/ml 1 h post-infection. The number of cells per well was
determined with a cell counter (Countess, Invitrogen) following
cell detachment with Trypsin/EDTA. Intracellular bacteria were
liberated by the addition of 0.2% Triton X-100 in PBS and
quantified by plating serial dilutions of cell lysates on BHI or LB
agar plates and numbering colony-forming units (CFU). Experi-
ments were performed in duplicates or triplicates and reproduced
three to five times. (ii) Mycobacterium infection. Before infection,
bacteria were washed twice and resuspended in 1 ml PBS. Clumps
were disassociated by passages through a needle, followed by
5 min of sedimentation. The density of bacteria in the supernatant
was checked at OD600 and correlated to the numeration of the
aliquot to allow 10 or 25 bacteria per cell. After 18 h of infection,
half of the cells were lysed for RNA extraction with RLT buffer
from RNeasy Mini Kit (Qiagen), and half were fixed in
paraformaldehyde and analyzed by flow cytometry to quantify
the percentage of infected cells (GFP-positive), using a FACS flow
cytometer (FACSCalibur, Becton Dickinson), as described pre-
viously [27]. Experiments were performed in duplicates and
reproduced four times. (iii) Chlamydia infections. Cells were
inoculated with Chlamydia at a MOI of 0.5 to 1. After 90 min at
37uC, the culture medium was changed and the plates returned to
37uC for 24 h before RNA extraction. Cells were fixed in 70%
ethanol and used to quantify the percentage of infected cells by
flow cytometry, using FITC-coupled anti-Chlamydia antibody
(Argene #12–114). Experiments were performed in quadrupli-
cates and reproduced once.
RNA Isolation, Reverse Transcription and Quantitative
Real Time PCR (qRT-PCR)
RNA from infected or uninfected cells was extracted using
RNeasy Mini Kit (Qiagen). Genomic DNA was removed by
treatment with TURBO DNA-free
TM kit (Ambion) and RNA
concentration and purity was assessed using NanoDrop spectro-
photometer (Thermo Scientific). First strand cDNA was synthe-
sized from 1 to 2 mg total RNA by using the RT
2 first strand kit
(SABioSciences, Qiagen) and quantitative PCR was performed
with RT
2 qPCR Primer Assay using the manufacturer’s protocol
(SABioSciences, Qiagen) and the recommended two-step cycling
program, on a MyIQ device (Bio-Rad). Each reaction was
performed in triplicate. All human and mouse qRT-PCR primers
were pre-designed, validated RT
2 qPCR primer pairs (SABioS-
ciences, Qiagen; see below). Relative gene expression was
normalized to GAPDH or YWHAZ reference gene transcription
and calculated with the DDCT method. Statistical analysis was
performed on triplicates from two to six independent experiments
using Student’s two-tailed T-test. A p-value p,0.05 was consid-
ered statistically significant. Primers used for qRT-PCR were pre-
designed, validated RT
2 qPCR primer pairs (SABioSciences,
Qiagen) as follows: for human genes, IL28A (IFN-l2,
PPH05847A), IL29 (IFN-l1, PPH05849A), IFNB1 (IFN-b,
PPH00384E), IFNG (IFN-c, PPH00380B), GAPDH
(PPH00150E), YWHAZ (PPH01017A), IL-8 (PPH00568A), and
for mouse genes IL28A (IFN-l2, PPM34810A), IL28B (IFN-l3,
PPM34810A), IFIT1 (PPM05530E), Mx1 (PPM05520A), Mx2
(PPM05503A), IGF2 (PPM03655A), GAPDH (PPM02946E) and
YWHAZ (PPM03697A).
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Cytokines in the supernatant of epithelial cells were quantified
with enzyme-linked immunosorbent assay (ELISA) according to
the manufacturer’s instructions, with the following references:
IFN-l1/l3 and IFN-l2 (Duoset ELISA kit, DY1598B and
DY1587, R&D Systems), IFN-b (VeriKine ELISAs, #41410-1A,
PBL Biomedical Laboratories, Piscataway, NJ, USA) and IL-8 (IL-
8 Ready-SET-Go!, #88–8086, eBioscience).
L. monocytogenes Infections, Quantification of IFN
Transcripts and Mx1 Staining in Mouse Placenta
Ethics statement. All animal experiments in the Pasteur
Institute were performed in accordance with protocols approved
by the animal Experimentation Ethics Committee of the Pasteur
Institute (permit #03–49). All animal experiments in the
University of Freiburg were performed in compliance with the
German animal protection law (TierSchG) and were approved
by the local animal welfare committees. The animals were
housed and handled in accordance with good animal practice as
defined by FELASA (www.felasa.eu/guidelines.php) and the
national animal welfare body GV-SOLAS (www.gv-solas.de/
index.html). Pregnant humanized E16P mEcad (E16P
+/+) [28]
and B6.A2G-Mx1-IFNAR1
0/0 [4–6] mice were used. (i) Murine
fetoplacental listeriosis experiments.4 610
4 bacteria in PBS were
injected intravenously in the tail vein of 10 week-old pregnant
homozygous knock-in mice expressing human E-cadherin (KI
E16P
+/+) [28] at gestation day 15/19. Non-infected pregnant
control mice were injected with PBS. After 72 h infection, as
described previously [28], animals were killed with CO2 and
aseptically dissected to isolate livers and placentas (6 to 12
placenta per pregnant mouse; atrophied placentas were not
further used). Livers were kept on ice, while placentas were
immediately frozen in liquid nitrogen and conserved at 280uC.
Livers were disrupted with a tissue homogenizer in 3 ml of PBS
and bacterial loads were determined by plating serial dilutions on
BHI agar plates. Two independent experiments were performed
with, respectively, 2 and 3 uninfected mice and 2 and 6 infected
mice. Frozen placentas from the two mice that displayed the
highest CFU numbers in liver lysates and from two uninfected
mice were processed for RNA extraction and bacterial
quantifications. Half of the placentas from each mouse were
disrupted with a GentleMACS Dissociator (Miltenyi Biotec) in
1 mL RLT buffer supplemented with b-mercaptoethanol. RNA
extraction from 350 mL of lysed organ was performed with
RNeasy Mini Kit (Qiagen). The remaining half placentas were
disrupted in 3 mL PBS with a tissue homogenizer and plated for
CFU quantification on agar plates. (ii) Study of IFN-l2 responses in
the placenta. Pregnant B6.A2G-Mx1-IFNAR1
0/0 mice [6] at
gestation day 14, were treated subcutaneously with 5 mgo f
mouse IFN-l2 (IL-28A; PeproTech) or PBS (mock) at 24 and
12 h prior to sacrifice. Embryos in utero were extracted, fixed
with formaldehyde and embedded in paraffin. Tissues were
sectioned and deparaffinized, followed by immunostaining for
IFN-inducible Mx1 protein, as reported previously [6].
Table 1. List of bacterial strains used in this study and their effect on IFN-III genes in epithelial cells.
Bacterial species Strain Reference
(a) Effect on IFN-III
(b)
Human cell
line Reference
(c)
Listeria monocytogenes EGDe ATCC-BAA-679 BUG1600 ++ LoVo [23] and this work
++ HepG2 This work
++ BeWo This work
++ JEG-3 [23]
++ Caco-2 This work
(d)
– HEK293 This work
(d)
– THP-1 This work
(d)
Listeria monocytogenes EGDe DinlA BUG1454 [57] – LoVo This work
Listeria monocytogenes EGDe DinlB BUG1455 [57] – LoVo This work
Listeria monocytogenes EGDe Dhly BUG2133 [58] +/2 LoVo This work
Listeria innocua Clip11262 ATCC BAA-680 BUG499 – LoVo This work
Listeria innocua (inlA) BUG1496 BUG1496 [31] + LoVo This work
Enterococcus faecalis OG1X BUG1491 [31] – LoVo This work
Enterococcus faecalis (inlA) BUG1497 [31] + LoVo This work
Staphylococcus epidermidis BUG1477 [31] – LoVo This work
Staphylococcus epidermidis (inlA) BUG1498 [31] + LoVo This work
Staphylococcus aureus SH1000 [59] ++ LoVo This work
Salmonella enterica serovar Typhimurium SL1344 ATCC SL1344 – LoVo This work
Shigella flexneri M90T [60] – LoVo This work
Chlamydia trachomatis serovar L2 VR902B ATCC VR902B +/2 LoVo This work
Mycobacterium tuberculosis (GFP) H37Rv [27] ++ A549 This work
(a) Reference of the strain.
(b) Effect on the expression of IFN-III. ‘‘++’’: high induction; ‘‘+’’: induction; ‘‘+/2’’: weak induction; ‘‘–’’: no induction.
(c) Reference for the observed effect on IFN-III genes.
(d) Data not shown.
doi:10.1371/journal.pone.0039080.t001
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L. monocytogenes Induction of IFN-III in LoVo Intestinal
Epithelial Cells Requires the Invasion Proteins InlA and
InlB and the Pore-forming Toxin LLO
In an attempt to analyze the mechanisms underlying
L. monocytogenes stimulation of IFN-III expression, we first de-
termined bacterial loads and the kinetics of IFN gene expression
over 24 h infection with L. monocytogenes in LoVo epithelial cells
(Fig. 1A). IFN-l1 and IFN-l2 mRNA levels increased ,10–20-
fold over the first 6 h post-infection and then remained at this
level until the 9 h time point. Subsequently, the mRNA levels
rose again, reaching 40–80 fold at 18 h and up to 300–500 fold
at 24 h. In contrast to this expression profile, IFN-b mRNA
levels remained as in uninfected cells during the first three hours
of infection. They then reached a plateau (,20-fold induction)
from 6 h to 18 h post-infection, and rose again up to ,200-fold
at 24 h. IFN-c mRNA levels remained below the limits of
detection of the assay, both in uninfected and infected LoVo
cells, consistent with the fact that IFN-c is produced primarily by
immune cells.
We followed in parallel the production of IFN proteins in cell
supernatants by ELISA assays. No IFN was detectable at any time
point, except IFN-l1/l3 at 24 h (Fig. 1B and data not shown).
Lysing the cells did not improve detection (data not shown). We
thus performed longer infection kinetics and examined the effect of
increasing the multiplicity of infection (MOI) on the production of
IFNs. Secreted IFN-l1/l3 and IFN-l2 were significantly detected
in supernatants of infected cells at 28 h post-infection and their
levels increased further at 42 h, reaching ,2000 pg/ml for IFN-
l1/l3 and ,500 pg/ml for IFN-l2, at a MOI of 50–100 (Fig. 1B).
In contrast, the levels of secreted IFN-b remained very low, close
to the detection limit of the ELISA assay, indicating that IFN-III
are the major interferons produced and secreted by LoVo cells in
response to L. monocytogenes infection.
The kinetics of IFN-l expression suggested that there were two
waves of gene activation (Fig. 1A) that might result initially from
bacterial internalization and later from bacterial escape from the
internalization vacuole and growth in the cytosol. To address this
possibility, we compared the transcription of IFN-l genes in LoVo
cells infected for 18 h with wild type L. monocytogenes or isogenic
DinlA, DinlB or Dhly strains. inlA and inlB encode L. monocytogenes
major invasion factors, which can both mediate listerial entry into
Figure 1. Characterization of L. monocytogenes-mediated induction of IFN-III genes in LoVo intestinal cells. A. LoVo intestinal epithelial
cells infected with L. monocytogenes at multiplicity of infection (MOI) of 20 for the indicated time were lysed and processed for quantification of
intracellular bacteria by counting colony-forming units (CFU) on agar plates, or for total cellular RNA extraction. Quantitative RT-PCR was performed
to determine relative IFN-l1, IFN-l2, IFN-b and IFN-c mRNA levels. The expression values were normalized to GAPDH transcript levels. Fold inductions
were calculated from DDCT values, using uninfected control cell values at the beginning of the experiment as a calibrator (=1). Values from three
independent experiments are expressed as mean 6 S.D. of the fold change. IFN-c mRNA levels were below the limits of detection ({). At 24 h post-
infection, fold change values in uninfected cells were 1.1260.84 for IFN-l1; 0.6260.39 for IFN-l2; 1.4360.76 for IFN-b. B. Culture supernatants from
LoVo cells infected with L. monocytogenes (L.m.), at the indicated time and MOI, were analyzed by ELISA for IFN production. Experiments were done in
triplicate and reproduced once. C. LoVo cells were infected for 18 h with wild type (wt) or isogenic DinlA, DinlB or Dhly L. monocytogenes strains
(MOI=25), or with L. innocua or L. innocua expressing inlA (MOI=25) or L. innocua expressing inlA (MOI=100, indicated by ‘‘100’’). Cells were
processed as described in (A). Values are expressed as mean 6 S.D of three independent experiments.
doi:10.1371/journal.pone.0039080.g001
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forming toxin that promotes bacterial escape into the host cytosol
[29,30]. As expected, mutant strains exhibited significantly
reduced number of intracellular bacteria, when compared to wild
type bacteria (Fig. 1C). Remarkably, expression of IFN genes in
cells infected with DinlA or DinlB mutant strains were nearly as low
as in uninfected cells (Fig. 1C). Induction of IFN-l genes was also
low in cells infected with hly-deficient bacteria, but not as much as
for inlA- and inlB-deficient bacteria. The contribution of entry and
vacuolar escape to Listeria-mediated induction of IFN-l genes was
further addressed by using the non-invasive species Listeria innocua,
which does not produce InlA, InlB and LLO, and can be
internalized into epithelial cells when expressing inlA [31,32].
While L. innocua had no effect on the expression of IFN-l genes,
InlA-mediated internalization of L. innocua triggered their tran-
scription, in a MOI-dependent manner (Fig. 1C). This result
strongly suggets that Listeria internalization into a vacuole is
sufficient to induce the expression of IFN-l genes. However,
induction levels always remained below that of L. monocytogenes,
which can reach the cytosol.
Taken together, these results indicate that L. monocytogenes-
mediated maximal induction of IFN-III in epithelial cells proceeds
from both bacterial entry and escape into the host cell cytoplasm.
Gram-positive Intracellular Bacteria Induce much more
IFN-III than Gram-Negative Bacteria in LoVo Epithelial
Cells
We next studied whether other bacterial species could induce
the expression of IFN-III genes in LoVo cells, starting with the
Gram-negative S. enterica sv. Typhimurium, as this species is known
to activate these genes in DCs [20]. Strikingly, IFN-l and IFN-
b gene expression profiles in Salmonella-infected cells (Fig. 2A)
showed a markedly different pattern than in Listeria-infected cells
(Fig. 1A). Transcript levels for both IFN slightly increased after 3 h
of infection and returned to basal levels at 6 h in Salmonella-
infected LoVo cells. This stimulation (,10-fold for IFN-l1 and
,3-fold for IFN-l2 and IFN-b) was considerably lower than that
reported in DCs [20]. Moreover, although Salmonella efficiently
replicated in LoVo cells, as seen by an increase in the number of
intracellular bacteria over time, there was no further induction of
IFN genes at later time points.
We then investigated the ability of other Gram-negative and
Gram-positive bacteria to induce the expression of IFN-III genes.
The numbers of intracellular bacteria were quantified in parallel
by gentamicin assays (Fig. 2B), except for the obligate intracellular
pathogen Chlamydia trachomatis, for which invasion efficiencies were
determined by flow cytometry (4768% of LoVo cells were positive
for C. trachomatis infection). As shown in Fig. 2B, 18 h post-
infection the levels of IFN-l1/l2 mRNAs did not increase upon
Salmonella infection, as described above (Fig. 2A), and increased by
,3-fold and , 8-fold upon Shigella flexneri or C. trachomatis
infection, respectively, compared to the level of these transcripts in
uninfected cells. These induction levels were far less than those
observed for the Gram-positive bacterium L. monocytogenes (Fig. 1A,
Fig. 2B). Like L. innocua, the non-invasive Gram-positive species
E. faecalis and S. epidermidis failed to induce IFN-l genes. However,
InlA-mediated internalization of these bacteria induced IFN-l1
and IFN-l2 by ,20–40-fold (Fig. 2B). We searched for another
Gram-positive organism that could enter into LoVo cells without
heterologous expression of inlA. Several studies showed that some
strains of Staphylococcus aureus can be internalized in epithelial cells
[33–35]. We found here that S. aureus SH1000 was significantly
internalized into LoVo cells and, importantly, stimulated the
expression of IFN-l1 and IFN-l2 transcripts by ,40–60-fold
(Fig. 2B). This result was confirmed at protein level. After 28 h of
infection, amounts of IFN-l1/l3 in supernatants of cells infected
with S. aureus were comparable to that in L. monocytogenes–infected
cells (Fig. 2C). In contrast, there was neither IFN-l1/l3 nor IFN-
l2 in supernatants of cells infected with S. enterica or S. flexneri
(Fig. 2C and data not shown). We noticed massive cell death in
Shigella-infected cells after 42 h infection, but IFN-ls remained
undectable in supernatants (data not shown). We checked that all
of these bacterial species induced comparable levels of IL-8,
a cytokine which is known to be induced by intracellular
pathogens in epithelial cells [36,37] (Fig. 2C). This indicates that
LoVo cells can sense both Gram-positive and Gram-negative
intracellular bacteria.
Altogether, these results highlight marked differences in the
ability of bacterial species to specifically induce IFN-III in
epithelial cells (Table 1) and suggest that Gram-positive bacteria
are better inducers than Gram-negative bacteria.
IFN-III Genes are Induced in A549 Lung Epithelial Cells in
Response to Mycobacterium Tuberculosis Infection
M. tuberculosis, the causative agent of human tuberculosis, is not
classified as either a Gram-positive or a Gram-negative bacterium.
A key feature of this facultative intracellular pathogen is its ability
to persist within human cells for long periods of time, especially in
lung alveolar macrophages. However, it has also been reported to
invade and replicate within alveolar epithelial type II pneumocytes
in vitro [38–40] and also in the lungs of infected patients [41]. It
was thus of interest to examine the effect of this major pathogen on
IFN-III gene expression in a human lung epithelial cell line. GFP-
expressing M. tuberculosis bacteria were incubated with A549 lung
cells for 18 h. At that time, 4161% of cells were positive for M.
tuberculosis, as determined by flow cytometry, and IFN-l1 and IFN-
l2 genes were induced by 25-fold and 120-fold, respectively
(Fig. 2D). This result suggests that IFN-III genes might be
produced in the lung epithelium during tuberculosis.
IFN-III Genes are Induced in Epithelial Cells of Different
Origins in Response to L. monocytogenes Infection
During listeriosis, L. monocytogenes targets epithelial cells of the
intestine, but also from other organs, such as the placenta and the
liver. We found that L. monocytogenes and inlA-expressing L. innocua
up-regulated IFN-III genes in human intestinal cells other than
LoVo cells (Caco-2 cells, data not shown), as well as in BeWo
trophoblastic cells (Fig. 3, Table 1). L. monocytogenes also highly
induced IFN-l1 in HepG2 hepatocytes. In this cell line, IFN-l2
mRNA levels slightly increased upon infection, but the steady-state
IFN-l2 levels in uninfected cells were below the detection limits,
preventing quantitative measurement of a fold change. In contrast,
L. monocytogenes infection had no effect on the expression of IFN-III
genes in two non-epithelial human cell lines (HEK293 embryonic
cells and THP-1 monocytes, data not shown). Thus, L. mono-
cytogenes might specifically trigger the expression of IFN-III genes in
its epithelial niches.
IFN-III and IFN-responsive Genes are up-regulated During
Mouse Fetoplacental Listeriosis
L. monocytogenes causes maternofetal infections in humans [42].
Since L. monocytogenes invades trophoblast cells in vivo [28] and
induces IFN-III genes in these cells in vitro, we examined the
possibility that IFN-l might be induced upon infection at the
placental barrier. A knock-in mouse line ubiquitously expressing
humanized E-cadherin, the receptor for the L. monocytogenes
invasion factor InlA, has been recently established for studying
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e39080Bacterial Induction of IFN-l Genes
PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e39080L. monocytogenes invasion of the placenta [28]. Bacterial loads, IFN-
l2 and IFN-l3 transcript levels (murine IFN-l1 being a pseudo-
gene) were quantified in placental homogenates 72 h after
intravenous inoculation of pregnant mice with L. monocytogenes
(Fig. 4A). We observed a 2-5-fold increase in the level of IFN-l2/
l3 mRNA in placentas extracted from infected pregnant mice; the
increase was statistically significant when compared to uninfected
controls (Fig. 4B). Similar results were obtained when the YWHAZ
housekeeping gene, which has greater expression stability than
GAPDH in placenta [43], was used for normalization instead of
GAPDH (data not shown).
In an attempt to examine whether genes stimulated by IFN
were induced in response to Listeria infection in the placenta, we
quantified the expression of representative IFN-responsive genes,
IFIT1 and Mx1/2, in placenta infected or not by L. monocytogenes.
As shown in Fig. 4C, 72 h after intravenous inoculation of mice
with L. monocytogenes, the expression of IFIT1 and Mx1/2 was
induced in placentas, in contrast to that of a control gene, IGF2.
These results indicate that L. monocytogenes infection can promote
IFN-l expression and an IFN response in the placenta.
IFN-l2 Induces a Response in the Mouse Placenta
Expression of IFN-responsive genes in infected placentas might
not only be due to IFN-III, as IFN-I induces similar set of genes
[11]. In fact, it is unknown whether the placenta can repond to an
IFN-III stimulus. To determine whether placental epithelial cells
could specifically respond to IFN-III in vivo, we used a reporter
mouse line that lacks IFN-I receptors (IFNAR1
0/0 mice) and
carries a functional Mx1 allele [4–6]. Staining for Mx1 in
IFNAR1
0/0 mice represents a powerful tool to identify cells that
specifically respond to IFN-III, as Mx1 is an IFN-induced protein
that rapidly accumulates in the nucleus of responsive cells [4–6].
Since these mice do not express the humanized E-cadherin
receptor, L. monocytogenes could not be used as a stimulus for the
IFN-III pathway in placental epithelial tissues of these mice.
Instead, we used purified recombinant IFN-l2 and observed that
subcutaneous treatment with this cytokine induced prominent
nuclear Mx1 staining in epithelial cells of the fetal membranes, as
well as decidual and labyrinth zones of the placenta (Fig. 5). This
result demonstrates that the fetoplacental tissue is highly re-
sponsive to IFN-III.
Discussion
In this study, we show that IFN-III are the major interferons
produced and secreted by epithelial cells in response to
L. monocytogenes infection, by mechanisms involving both the
internalization and cytosolic phases of infection. We report that
other major bacterial pathogens, M. tuberculosis and the Gram-
positive cocci S. aureus, also stimulate type III IFN expression in
epithelial cells. In contrast, Gram-negative pathogens S. enterica,
S. flexneri and C. trachomatis have no or only weak effects. We also
Figure 2. Induction of IFN-III genes by different bacterial species in epithelial cells. A. LoVo intestinal cells infected with S. enterica at
multiplicity of infection (MOI) of 20 for the indicated time, were lysed and processed for quantification of intracellular bacterial by counting colony-
forming units (CFU) on agar plates, or for total cellular RNA extraction and quantification of IFN gene expression, as described for L. monocytogenes in
Figure 1A. Values from three independent experiments are expressed as mean 6 S.D. of the fold change relative to uninfected control cell values at
the beginning of the experiment. B. LoVo cells, uninfected or infected for 18 h with different bacterial species, were processed for quantification of
bacterial load and mRNA. Quantification of internalized bacteria: data are means 6 S.D. of CFU for 10
5 cells (n=3) at the indicated MOI, except for
C. trachomatis, for which the percentage of infected cells (n=4) were determined by flow cytometry after antibody labelling (see text). IFN-l1 and
IFN-l2 transcript levels were determined by qRT-PCR and normalized to GAPDH transcript levels. Values are expressed as mean 6 S.D. of the fold
change relative to that in uninfected cells (n=3 to 5). C. Quantification of IFN-l1/l3 and IL-8 production were done by ELISA, using culture
supernatants of LoVo cells infected for 28 h with the indicated bacterium at a MOI of 50. Experiments were done in triplicates and reproduced once.
D. Quantification of IFN-l mRNAs in A549 lung epithelial cells infected with GFP-expressing M. tuberculosis (n=4). The percentage of infected cells
were determined by flow cytometry (see text).
doi:10.1371/journal.pone.0039080.g002
Figure 3. Induction of IFN-III genes by L. monocytogenes in HepG2 hepatocytes and BeWo trophoblastic cells. Quantification of bacterial
loads (CFU) and IFN-l mRNAs levels in Listeria-infected HepG2 or BeWo cells. IFN-l1 and IFN-l2 transcript levels were determined by qRT-PCR and
normalized to GAPDH transcript levels. Values are expressed as mean 6 S.D. of the fold change relative to that in uninfected cells (n=3). IFN-l2 levels
in uninfected HepG2 cells were below the detection threshold, preventing measures of fold change. L. monocytogenes (L. m.), L. innocua (L. in.),
L. innocua expressing inlA (L. in. (inlA)).
doi:10.1371/journal.pone.0039080.g003
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infection of placental tissue by L. monocytogenes. IFN-I and IFN-III
genes can potentially be expressed by all nucleated cells,
following the activation of pattern recognition receptors (PRR)
by microbial products [21,22]. Most studies have nevertheless
focused on the expression of these genes in immune cells or
fibroblasts. The results presented here highlight that there are
marked and intriguing differences between bacterial species in
their ability to activate IFN-III genes in epithelial cells, and this
could play an important role in epithelial immunobiology.
Among different bacteria tested, L. monocytogenes highly induces
IFN-l1/l2 transcription in intestinal cells and other cells of
epithelial origin, such as cytotrophoblast and hepatocytes,
extending our previous findings [23]. Induction of IFN-III genes
by L. monocytogenes in epithelial LoVo cells occurs in two waves, the
first probably involving InlA- and InlB-mediated internalization,
and the second involving cellular events promoted by LLO-
mediated vacuolar escape. Based on these observations, we
hypothesize that both vacuolar and cytosolic immune surveillance
pathways contribute to IFN-III production. Indeed, it has been
shown that L. monocytogenes infection induces distinct immune
responses in macrophages, depending on whether it acts on the
plasma membrane, the vacuole or the cytosol [44,45]. However,
LLO-deficient bacteria fail to induce type I IFN in these immune
Figure 4. Induction of IFN-III and IFN-stimulated genes in mouse placenta. Pregnant E16P
+/+ mice were inoculated intravenously with
4610
4 CFUs L. monocytogenes in PBS (L.m.) or with PBS only (n.i.) in two independent experiments (exp. A and B). Bacterial numbers were determined
in livers and placentas 72 h post-infection. Placentas (n=7 in exp.A; n=8 in exp.B) from the two mice that displayed the highest bacterial loads in
liver lysates, and placentas (n=3) from two uninfected mice (n.i.), were processed for RNA extraction and bacterial quantifications. A. Quantification
of L. monocytogenes loads and IFN-l transcripts in placenta homogenates. B. Quantification of IFN-l2 and IFN-l3 transcript levels in placentas by qRT-
PCR, with normalization to GAPDH transcripts. Values are expressed as mean 6 S.D. of the fold change relative to that in placenta of uninfected
mouse A1 or mouse B1 (=1). There is no significant change in uninfected mouse A2 or mouse B2 (n.i. A2, n.i. B2).C .Quantification of transcript levels
of IFN-responsive genes (IFIT1, Mx1, Mx2) and a control gene (IGF2) in placentas were determined by qRT-PCR and normalized to YWHAZ
housekeeping gene. Values are expressed as mean 6 S.D. of the fold change relative to that in placenta of all uninfected mice of exp.A or exp.B.
(*p,0.05; **p,0.005, Student t test).
doi:10.1371/journal.pone.0039080.g004
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responsible for L. monocytogenes-induced IFN-I [46]. Here, we found
that while internalization contributes to IFN-l induction in
epithelial cells, LLO-deficient bacteria are only partially defective
in eliciting this response. Moreover, IFN-l1/l2 genes start to be
expressed earlier than IFN-b upon infection, and IFN-ls are
produced at higher level than IFN-b. These differences suggest
that IFN-III induction during epithelial cell infection may not use
the same mechanisms than those leading to IFN-I expression in
macrophages [18,21,45,47]. In this respect, Listeria could be
a useful tool to investigate such specificities.
We highlight that other Gram-positive bacteria also significantly
induce the expression of IFN-III genes upon internalization in
epithelial cells. In particular, two major pathogens, S. aureus and
M. tuberculosis, induce IFN-l in LoVo intestinal and A549 lung
epithelial cells, respectively. Both species lead to chronic infections
in humans, and an emerging body of evidence suggests that they
can reside as intracellular pathogens in epithelial cells [33–35,38–
40], which would constitute a reservoir involved in bacterial
persistence in vivo [41,48–50]. Interestingly, IFN-III was recently
described as a modulator of the T-helper 2 (Th2) response, with
inhibitory effects on Th2 cell-mediated inflammation [51,52], as
well as a suppressor of allergy in the lung [53]. Therefore, it is
possible that continuous induction of IFN-III by epithelial cells in
mucosa may strategically help persistence of these pathogens.
In contrast, Gram-negative S. flexneri, S. enterica and C. trachomatis
species do not or only weakly induce IFN-l genes in LoVo cells,
suggesting that Gram-negative and Gram-positive organisms
might differentially target PRR signaling cascades leading to
IFN-III production in epithelial cells. Such differences in the
induction of immune response genes between different groups of
bacteria have been reported in other cells types; for instance,
Gram-positive and Gram-negative bacteria induce different
patterns of pro-inflammatory cytokines in human monocytes
[54]. The differences observed do not seem to result from different
amounts of intracellular bacteria (Fig. 2B) or from localization in
different cellular compartments. L. monocytogenes and S. flexneri
replicate in the cytosol with similar efficiency, yet only L. mono-
cytogenes stimulates IFN-III production. The differences between
Gram-positive and Gram-negative bacteria might result from
production of distinct MAMPs and/or factors influencing IFN
signaling pathways, or from epithelial cell specificities in the
repertoire of PRRs. In fact, LPS that is produced by both Shigella
and Salmonella activates IFN-l genes in other cell types [19,20] and
S. enterica itself induces IFN-l in DCs [20]. However, as shown
here, these enteropathogens do not trigger expression of IFN-l
Figure 5. Response to IFN-III in mouse placenta and fetal membrane. Pregnant B6.A2G-Mx1-IFNAR1
0/0 mice were treated subcutaneously
with 5 mg of mouse IFN-l2 or PBS (mock) at 24 and 12 h prior to sacrifice. Embryos in utero were extracted and fixed with formaldehyde. Sections of
paraffin-embedded tissue were immuno-stained for IFN-inducible Mx1 protein. IFN-l response was monitored by nuclear Mx1 staining (red) in
epithelial cells of the fetal membrane and various regions of the placenta. Counterstaining: background auto-fluorescence (white). Zooms of squared
regions are shown below. Scale bar: 50 mm.
doi:10.1371/journal.pone.0039080.g005
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to actively dampen IFN-III expression in this cell type.
So far, the function of IFN-III in bacterial infection is unknown.
From viral infection studies [4–6] and owing to the receptor
restricted expression pattern, it is tempting to speculate that IFN-l
contributes to epithelial innate immunity in response to bacteria,
but not necessarily for the host benefit. Indeed, while type II IFN
(IFN-c) has antibacterial activity, type I IFN favors L. monocytogenes
and M. tuberculosis persistence [21,22]. A first step before un-
derstanding the role of IFN-III in bacterial infectious diseases, in
particular listeriosis, was to find out whether these genes are
induced in epithelial tissues in vivo. To address this question, we
used a mouse model in which L. monocytogenes can efficiently invade
epithelial cells due to the expression of its humanized receptor E-
cadherin [28]. Listeria colonizes several tissues of epithelial origins
such as the the liver, intestine and placenta. We chose to study the
expression of IFN-III in the murine placenta for three reasons: (i)
the placenta has not yet been described as an IFN-l-producing or
-responsive tissue; (ii) IFN-l elicits a response in the mouse
intestine [55], but this tissue is in contact with the numerous
bacteria of the microbiota, which may affect IFN production; (iii)
IFN-l receptor is expressed at very low levels in mouse liver, in
contrast to human liver, and thus IFN-l has no effect in this organ
in the mouse model [4,55,56]. We report that levels of IFN-l2 and
IFN-l3 mRNAs and that of the IFN-responsive genes IFIT1 and
Mx1/2 are increased in the placenta infected with L. monocytogenes,
indicating that IFN-III may participate in the immune response at
the fetoplacental barrier. Supporting this hypothesis, cells of the
fetal membranes and decidual and labyrinth zones of the mouse
placenta respond to IFN-l2 treatment (Fig. 5).
Whether IFN-l could mediate protection of the fetus from
invading Listeria, or alternatively, whether this pathway is
beneficial for the pathogen, for instance by stimulating abortion
that leads to bacterial release in the environment, deserves future
investigations. In this regard, in-depth analysis of infection kinetics
and the establishment of new animal models are required, in
particular generation of a mouse line that would be both
permissive for Listeria infection of epithelia and impaired in IFN-
III responses. However, one should keep in mind that the mouse
model may not be optimal to address the role of IFN-III in human
listeriosis, since IFN-l1 is a pseudogene in mice, while human cells
produce this cytokine upon infection with L. monocytogenes.
Most pathogenic bacteria target tissues of epithelial origin, such
as skin, throat, gut, liver, lung, genital mucosa or placenta. We
propose that some bacterial species allow epithelial cells to become
a source of IFN-ls, acting as paracrine immunomodulators of
mucosal surfaces. Dissecting the mechanisms of IFN-III pro-
duction and function during bacterial diseases may have important
implications for diagnostic and therapeutic developments.
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